Alimera Sciences reported $43.13M in Debt for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Abbvie ABBV:US $ 86056M 1003M
Aerie Pharmaceuticals AERI:US $ 210.37M 5.68M
Alimera Sciences ALIM:US $ 43.13M 1.18M
Applied Genetic Technologies AGTC:US $ 9.91M 0.07M
Bayer BAYN:GR € 41766M 1684M
Insmed INSM:US $ 372.11M 5.4M
Novartis NOVN:VX SF 38049M 126M
Ophthotech OPHT:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2695.7M 0.9M